is one of the forces transforming
health care and reshaping the pharmaceutical market place. They are revisiting
barriers in asthma care:
lack of familiarity with and/or
agreement with the guidelines,
of confidence in being able to carry out the best practice,
to overcome clinical inertia related to previous practices,
barriers such as time constraints in the office
patient preference, and
of tools or support to carry out the recommendations.
is new is the opportunity to submit comments to AHRQ on evidence, sources of
evidence or other approaches that have helped physicians implement guidelines
so that the patients receive the best care.
AHRQ has requested public comments on 3 key questions related to
physician adherence to asthma guidelines. They have cited barriers that
were identified in research in 2004-2007 and are seeking input on more current
evidence related to interventions that increase adherence to guidelines and are
linked to better patient outcomes. If you have positive experiences with
evidence that improves asthma patient care and outcomes that should be included
in your comments.
can find the AHRQ form and the background paper by clicking this
hyperlink: Asthma and AHRQ. Please
let us know if we can assist you in developing and submitting comments to AHRQ.
SMT multi-disciplinary team has
extensive experience with clinical guidelines and links to process and outcomes
measure. Improvements in performance
measures can address gaps in care that can
in turn improve appropriate care, expanding market size by inpelling more patients to receive
appropriate pharmacologic care.
more information on SMT and on our Public Comment service please feel free to